A participant in a clinical trial for end-of-life distress died by suicide two weeks after receiving a subtherapeutic 1-mg dose of psilocybin, although treatment-emergent suicidality has not been reported in trials.

Authors

• Person: Raquel Consul, Flávia Lucas, Maria Graça Campos Organization: Taylor & Francis
  Altered states of consciousness – Knowledge and References

Sources

• Altered states of consciousness – Knowledge and References taylorandfrancis.com Raquel Consul, Flávia Lucas, Maria Graça Campos · Taylor & Francis via serper

Referenced by nodes (2)

• psilocybin concept
• suicidality concept